Genomictree Inc. (KOSDAQ:A228760) announced that it will issue 775,192 convertible preferred shares at a price of KRW 12,900 per share for gross proceeds of KRW 9,999,976,800 and round 1 unregistered coupon nonguaranteed private convertible bonds for gross proceeds of KRW 50,000,000,000 on April 22, 2021. The preferred share transaction will include participation from Fund 1 for 77,519 shares, Fund 2 for 116,279 shares, Fund 3 for 155,038 shares, Fund 4 for 232,558 shares, and Fund 5 for 193,798 shares and the bonds transaction will include participation from a group of investors including funds managed by ANDA Asset Management Co., Ltd. for KRW 8,000,000,000, Hanyang Securities Co., Ltd., Investment Arm for KRW 2,000,000,000 and C-Square Asset Management for KRW 5,000,000,000. The company will raise the preferred share funding through third party allocation method. Each preferred share is convertible into one common shares of the company at a fixed conversion price of KRW 12,900 from April 30, 2022 to April 29, 2026. The bonds are zero coupon bonds with no yield to maturity, are being issued at par and will mature on April 30, 2026. The bonds are fully convertible into 3,397,413 common shares representing 14.53% stake at a conversion price of KRW 14,717 per share from April 30, 2022 to March 30, 2026. The transaction has been approved by the board of directors of the company, and is expected to close on April 30, 2021. The subscription date of the bonds transaction is on April 26, 2021. The bonds are subject to a hold period of one year.